IRIS
SORRENTINO, SABATO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 597
EU - Europa 298
AS - Asia 289
SA - Sud America 2
AF - Africa 1
Totale 1.187
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 586
SG - Singapore 213
IT - Italia 140
CN - Cina 51
SE - Svezia 34
DE - Germania 31
NL - Olanda 30
GB - Regno Unito 22
FI - Finlandia 18
HK - Hong Kong 13
CA - Canada 10
FR - Francia 6
JP - Giappone 5
RO - Romania 4
IN - India 3
BE - Belgio 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
PT - Portogallo 2
AT - Austria 1
BR - Brasile 1
CL - Cile 1
EE - Estonia 1
GR - Grecia 1
IQ - Iraq 1
MA - Marocco 1
MX - Messico 1
MY - Malesia 1
PK - Pakistan 1
RU - Federazione Russa 1
UA - Ucraina 1
VN - Vietnam 1
Totale 1.187
Salva come PNG Salva come JPEG
Città #
Chandler 103
Singapore 98
Santa Clara 95
Milan 50
Lawrence 34
Princeton 34
Ashburn 24
London 20
Wilmington 20
Helsinki 18
Chicago 16
Munich 15
Hong Kong 12
Rome 11
Assago 10
Ottawa 9
Shanghai 8
Boardman 7
Des Moines 7
Amsterdam 6
Catanzaro 6
Redmond 6
Hanover 5
Madison 4
Tokyo 4
Augusta 3
Bari 3
Buffalo 3
Ferrara 3
Guangzhou 3
Portofino 3
Redwood City 3
San Francisco 3
Beijing 2
Bocale 2
Cosenza 2
Hasselt 2
Horia 2
Los Angeles 2
Naples 2
Perugia 2
San Nicola Manfredi 2
Seattle 2
Terlizzi 2
Trento 2
Verona 2
Vibo Valentia 2
Washington 2
Bengaluru 1
Berlin 1
Bolzano 1
Bremen 1
Brescia 1
Casoria 1
Chengdu 1
Clifton 1
Eden Prairie 1
Elk Grove Village 1
Esslingen am Neckar 1
Forest City 1
Genova 1
Hanoi 1
Houston 1
Krasnoyarsk 1
Kuala Lumpur 1
Laayoune 1
Lisbon 1
Locate Bergamasco 1
Mexico City 1
New York 1
Nideggen 1
North York 1
Norwalk 1
Nuremberg 1
Olomouc 1
Palermo 1
Pitesti 1
Porto 1
Prague 1
Pune 1
Qingdao 1
San Ramon 1
Sant'Agata Bolognese 1
Shenzhen 1
São Paulo 1
Tongchuanshi 1
Torino 1
Trieste 1
Wuhan 1
Totale 717
Salva come PNG Salva come JPEG
Nome #
Empagliflozin prevents doxorubicin-induced myocardial dysfunction 50
Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials 39
Hand Laser Perfusion Imaging to Assess Radial Artery Patency: A Pilot Study. 39
B-Type Natriuretic Peptide as Biomarker of COVID-19 Disease Severity-A Meta-Analysis 38
Hindlimb Ischemia Impairs Endothelial Recovery and Increases Neointimal Proliferation in the Carotid Artery. 37
Indirect Comparison of the Efficacy and Safety of Alirocumab and Evolocumab: A Systematic Review and Network Meta-Analysis 36
Mir-16 Modulates Endothelial Dysfunction After Balloon Injury in a Rat Model of Chronic Peripheral Ischemia. 35
The Role of Mir-16 on Endothelial Dysfunction in Rat with Atherosclerotic Diet with a Chronic Model of Femoral Artery Occlusion and Carotid Balloon Injury. 34
Dual anti-thrombotic treatment with direct anticoagulants improves clinical outcomes in patients with Atrial Fibrillation with ACS or undergoing PCI. A systematic review and meta-analysis 34
Down-Regulation of miR-23/27/24 Clusters by TGF-beta 1 Signalling Induces Phenotypic Switching of Vascular Smooth Muscle Cells in vitro and in Response to Vascular Injury in vivo. 33
Corrigendum to “miR-125a-5p Modulates Phenotypic Switch of Vascular Smooth Muscle Cells by Targeting ETS-1” (J. Mol. Biol. Jun 16 2017; 429(12):1817–1828) (S002228361730222X) (10.1016/j.jmb.2017.05.008) 29
Early Aspirin Discontinuation Following Acute Coronary Syndrome or Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 28
Predictors of outcomes in patients with mitral regurgitation undergoing percutaneous valve repair 28
New Antithrombotic Strategies and Coronary Stent Technologies for Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention 28
Flow-Responsive Noncoding RNAs in the Vascular System: Basic Mechanisms for the Clinician 27
Multichannel Electrocardiograms Obtained by a Smartwatch for the Diagnosis of ST-Segment Changes 27
Instantaneous wave-Free Ratio (iFR) and Gradient (iFG): new promising adenosine-independent alternative to fractional flow reserve. Preliminary results from the FORECAST Study. 24
Direct Oral Anticoagulants in Patients With Active Cancer 24
Delayed sudden radial artery rupture after left transradial coronary catheterization: a case report. 23
MicroRNA-1 Downregulation Increases Connexin 43 Displacement and Induces Ventricular Tachyarrhythmias in Rodent Hypertrophic Hearts. 23
Early reduction of left atrial function predicts adverse clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement 22
Non-invasive myocardial work is reduced during transient acute coronary occlusion 21
Modulation of Circulating MicroRNAs Levels during the Switch from Clopidogrel to Ticagrelor. 20
Differences in coagulopathy indices in patients with severe versus non-severe COVID-19: a meta-analysis of 35 studies and 6427 patients 20
The duration of balloon inflation affects the luminal diameter of coronary segments after Bioresorbable Vascular Scaffolds deployment 19
The instantaneous wave-Free Ratio (iFR) for evaluation of non culprit lesions in patients with Acute Coronary Syndrome and multivessel disease. 19
Prediction of Significant Coronary Artery Disease Through Advanced Echocardiography: Role of Non-invasive Myocardial Work 19
Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients for the Treatment of Severe Aortic Stenosis 18
Down-regulation of miR-23b induces phenotypic switching of vascular smooth muscle cells in vitro and in vivo 18
Standard Versus Ultrasound-Guided Cannulation of the Femoral Artery in Patients Undergoing Invasive Procedures: A Meta-Analysis of Randomized Controlled Trials 17
Cellular and Molecular Mechanisms Underlying Tricuspid Valve Development and Disease 16
Reliability of Instantaneous Wave-Free Ratio (iFR) for the Evaluation of Left Main Coronary Artery Lesions 16
Stent Thrombosis After Percutaneous Coronary Intervention: From Bare-Metal to the Last Generation of Drug-Eluting Stents 16
Non-Invasive Myocardial Work in Patients with Severe Aortic Stenosis 16
The Effects of Statins, Ezetimibe, PCSK9-Inhibitors, Inclisiran, and Icosapent Ethyl on Platelet Function 14
Strategies to Minimize Access Site-related Complications in Patients Undergoing Transfemoral Artery Procedures with Large-bore Devices 14
null 14
[Debate on dual pathway inhibition: Antiplatelet and anticoagulant therapies in patients undergoing percutaneous coronary intervention at high risk for recurrent ischemic events. Focus on anticoagulation-based strategies] 13
Antithrombotic therapy and cardiovascular outcomes after transcatheter aortic valve implantation in patients without indications for chronic oral anticoagulation: a systematic review and network meta-analysis of randomized controlled trials 13
Risk of Bleeding in Elderly Patients Undergoing Transcatheter Aortic Valve Implantation or Surgical Aortic Valve Replacement 13
Clinical and Procedural Outcomes of 5-French versus 6-French Sheaths in Transradial Coronary Interventions 13
Single Versus Dual Antiplatelet Therapy Following TAVR: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 12
Simultaneous Radial and Ipsilateral Ulnar Artery Compression versus Isolated Radial Artery Compression after Conventional Radial Access for Coronary Angiography and/or Intervention: A Systematic Review and Meta-Analysis 12
Small‐vessel PCI outcomes in men, women, and minorities following platinum chromium everolimus‐eluting stents: Insights from the pooled PLATINUM Diversity and PROMUS Element Plus Post‐Approval studies 11
Effect of valve design and anticoagulation strategy on 30‐day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial 11
Coronary Calcification and Long-Term Outcomes According to Drug-Eluting Stent Generation 11
The prevalence, predictors and outcomes of guideline‐directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry 10
Acute expansion of nitinol-based self-expandable device in patients undergoing transfemoral aortic valve implantation 10
Incidence, Predictors, and Prognostic Impact of Neurologic Events After TAVR According to VARC-3 Criteria 10
The link between anemia and adverse outcomes in patients with acute coronary syndrome 9
Cerebral Embolic Protection During TAVR 9
Impact of Baseline Atrial Fibrillation on Outcomes Among Women Who Underwent Contemporary Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry) 9
Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: A post hoc analysis from the BRAVO‐3 randomized trial 9
Sex‐Related Differences in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Patient‐Level Pooled Analysis From 4 Postapproval Studies 9
Unmet Needs in TAVR: Conduction Disturbances and Management of Coronary Artery Disease 9
Limitations of Current Risk Scoring in Real World Populations: The Importance of External Validation 8
Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk 8
Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention 8
Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry) 8
The importance of the Heart Team evaluation before transcatheter aortic valve replacement: Results from the BRAVO‐3 trial 8
Acute Kidney Injury After Transcatheter Aortic Valve Replacement Mediates the Effect of Chronic Kidney Disease 8
Edwards SAPIEN Versus Medtronic Aortic Bioprosthesis in Women Undergoing Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry) 7
White blood cell count and clinical outcomes after left main coronary artery revascularization: insights from the EXCEL trial 7
Impact of renal function in high bleeding risk patients undergoing percutaneous coronary intervention: a patient-level stratified analysis from four post-approval studies 7
Paravalvular Leak 7
Temporal trends, determinants, and impact of high-intensity statin prescriptions after percutaneous coronary intervention 7
Temporal Trends in Statin Prescriptions and Residual Cholesterol Risk in Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention 7
Bioprosthetic leaflet thrombosis and reduced leaflet motion after transcatheter aortic valve replacement: A systematic review and meta-analysis 7
Stent Thrombosis and Restenosis with Contemporary Drug-Eluting Stents: Predictors and Current Evidence 6
Common Calcified Femoral Artery Rupture After Intravascular Lithotripsy for TAVR Implantation 6
Mechanical heart valves between myths and new evidence: a systematic review and meta-analysis 6
Feasibility of measuring patient-reported health status at time of percutaneous coronary intervention: Results from a single-center quality-improvement initiative 6
Safety and efficacy of nonvitamin K antagonist oral anticoagulants during catheter ablation of atrial fibrillation: A systematic review and meta‐analysis 6
Stent Thrombosis After Percutaneous Coronary Intervention 6
Effects of Body Mass Index on Clinical Outcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents 6
Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention 6
Rationale for Early Administration of PCSK9 Inhibitors in Acute Coronary Syndrome 6
Associations Between Complex PCI and Prasugrel or Clopidogrel Use in Patients With Acute Coronary Syndrome Who Undergo PCI: From the PROMETHEUS Study 5
Incidence and outcomes of transient new-onset atrial fibrillation complicating acute coronary syndromes: results from a systematic review and meta-analysis 5
Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age 5
The Telecardiology Revolution: From Emergency Management to Daily Clinical Practice 5
Reduction of hospitalisations and increased mortality for acute coronary syndromes during covid-19 era: Not all countries are equal 5
Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention 5
Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention—Results from the PROMETHEUS registry 5
Impact of pre‐existing or new‐onset atrial fibrillation on 30‐day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial 5
Impact of coronary artery disease and percutaneous coronary intervention in women undergoing transcatheter aortic valve replacement: From the WIN‐TAVI registry 5
Calculated Serum Osmolality, Acute Kidney Injury, and Relationship to Mortality after Percutaneous Coronary Intervention 4
Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction 4
Assessing and minimizing the risk of percutaneous coronary intervention in patients with chronic kidney disease 4
Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry 4
Determinants of Significant Out-Of-Hospital Bleeding in Patients Undergoing Percutaneous Coronary Intervention 4
Clinical manifestations and outcomes of coronavirus disease‐19 in heart transplant recipients: a multicentre case series with a systematic review and meta‐analysis 3
Use of prasugrel vs clopidogrel and outcomes in patients with and without diabetes mellitus presenting with acute coronary syndrome undergoing percutaneous coronary intervention 3
Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry) 3
Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions 2
Geographical Variations in Patterns of DAPT Cessation and Two-Year PCI Outcomes: Insights from the PARIS Registry 2
Totale 1.357
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.948
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.948
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202018 0 0 0 0 0 0 0 0 0 0 11 7
2020/202183 29 1 12 0 10 4 5 6 5 3 2 6
2021/2022117 0 0 3 29 10 4 0 27 11 13 17 3
2022/2023352 74 12 40 12 45 28 3 26 52 21 30 9
2023/2024235 28 22 12 12 3 42 0 13 64 5 20 14
2024/2025545 97 35 34 22 61 137 43 16 79 15 6 0
Totale 1.357